Horizon Discovery Inks Additional Licensing Pacts with U of Washington | GenomeWeb

NEW YORK (GenomeWeb News) – Horizon Discovery and the University of Washington said today that they have entered into a pair of additional licensing agreements in the area of human gene targeting.

The new agreements give Cambridge, UK-based Horizon the exclusive right to commercialize inventions made by UW researcher David Russell, relating to the use of parvoviral vectors in human genome engineering.

In exchange, UW will be granted an undisclosed number of shares in Horizon and will receive ongoing product royalties from licensed products and services.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.